当前位置: X-MOL 学术J. Pharm. Innov. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Nanonization-Based Solubility Enhancement by Loaded Porous Starch Foam: Nifedipine Tablet Formulation
Journal of Pharmaceutical Innovation ( IF 2.7 ) Pub Date : 2022-02-17 , DOI: 10.1007/s12247-022-09622-4
Pratibha Milind Chaudhari 1 , Paul Johnson 1 , Antoine Al-Achi 1 , Raksha Laxman Mhetre 2
Affiliation  

Background

Nifedipine (NIF) is a 1,4-dihydropyridine, calcium channel blocker, widely used in the treatment of cardiovascular diseases. NIF is poorly soluble in water at room temperature. Biodegradable porous starch foam (BPSF) has great potential as a solid dispersion carrier and can improve the solubility of poorly water-soluble drugs like NIF.

Objective

To formulate and evaluate tablet formulation of nifedipine-loaded biodegradable porous starch foam to improve the solubility of the drug.

Methods

The physical properties and the dissolution profile of NIF/BPSF mixtures and tablets were investigated. The BPSF was prepared by using a solvent exchange method, and NIF was loaded using an immersion/solvent evaporation method. The samples were characterized using differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), powder X-ray diffraction (PXRD), and optical microscopy.

Results

The in vitro dissolution studies demonstrated the immediate release of NIF from the BPSF formulated tablets. The formulation containing a ratio of NIF:BPSF (1:10) gave around 70% drug release in 30 min as compared to the control NIF tablets that showed 11% drug release.

Conclusion

These results showed an increase in the drug release of NIF from BPSF as a carrier thereby supporting the mechanism of drug adsorption.



中文翻译:

负载多孔淀粉泡沫基于纳米化的溶解度增强:硝苯地平片剂配方

背景

硝苯地平 (NIF) 是一种 1,4-二氢吡啶类钙通道阻滞剂,广泛用于治疗心血管疾病。NIF 在室温下难溶于水。可生物降解的多孔淀粉泡沫(BPSF)作为固体分散载体具有很大的潜力,可以提高NIF等水溶性差的药物的溶解度。

客观的

制定和评估负载硝苯地平的可生物降解多孔淀粉泡沫的片剂配方,以提高药物的溶解度。

方法

研究了 NIF/BPSF 混合物和片剂的物理性质和溶出曲线。BPSF 采用溶剂交换法制备,NIF 采用浸没/溶剂蒸发法加载。使用差示扫描量热法 (DSC)、傅里叶变换红外光谱 (FTIR)、粉末 X 射线衍射 (PXRD) 和光学显微镜对样品进行表征。

结果

体外溶出研究表明,NIF 从 BPSF 配制的片剂中立即释放。与显示 11% 药物释放的对照 NIF 片剂相比,含有比例 NIF:BPSF (1:10) 的制剂在 30 分钟内产生约 70% 的药物释放。

结论

这些结果表明,作为载体的 BPSF 中 NIF 的药物释放增加,从而支持药物吸附机制。

更新日期:2022-02-18
down
wechat
bug